市場調査レポート：世界の幼児/女性用プロバイオティクス市場（～2028年）：プロバイオティクスパウダー、プロバイオティクスドロップ、プロバイオティクスカプセル

• 英文タイトル：Global Probiotics for Infants and Women Market Insights, Forecast to 2028

Global Probiotics for Infants and Women Market Insights, Forecast to 2028「世界の幼児/女性用プロバイオティクス市場（～2028年）：プロバイオティクスパウダー、プロバイオティクスドロップ、プロバイオティクスカプセル」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC2Q12-19367
• 出版社/出版日：QYResearch / 2022年12月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、115ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：医薬品＆医療

• 販売価格（消費税別）

Single User	￥710,500 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,421,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、幼児/女性用プロバイオティクスのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
幼児/女性用プロバイオティクスのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
幼児/女性用プロバイオティクスの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
幼児/女性用プロバイオティクスのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの幼児/女性用プロバイオティクスの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の幼児/女性用プロバイオティクスの売上および2028年までの予測に焦点を当てています。

幼児/女性用プロバイオティクスのグローバル主要企業には、DowDuPont、Koninklijke DSM、Pantheryx、Gerber Products、BioGaia、Metagenics、i-Health、LoveBug Nutrition、NOW Foods、By-Health、ChildLife、Nemans、CNFONO、Angel Yeast、Taiwan Xinyao livelihood、Weihai Baihe Biotechnology、Shanghai Yili Health、Beijing Hanmei Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

幼児/女性用プロバイオティクス市場は、タイプとアプリケーションによって区分されます。世界の幼児/女性用プロバイオティクス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
プロバイオティクスパウダー、プロバイオティクスドロップ、プロバイオティクスカプセル

【アプリケーション別セグメント】
幼児、女性

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 幼児/女性用プロバイオティクス製品概要
- タイプ別市場（プロバイオティクスパウダー、プロバイオティクスドロップ、プロバイオティクスカプセル）
- アプリケーション別市場（幼児、女性）
- 調査の目的
・エグゼクティブサマリー
- 世界の幼児/女性用プロバイオティクス販売量予測2017-2028
- 世界の幼児/女性用プロバイオティクス売上予測2017-2028
- 幼児/女性用プロバイオティクスの地域別販売量
- 幼児/女性用プロバイオティクスの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別幼児/女性用プロバイオティクス販売量
- 主要メーカー別幼児/女性用プロバイオティクス売上
- 主要メーカー別幼児/女性用プロバイオティクス価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模（プロバイオティクスパウダー、プロバイオティクスドロップ、プロバイオティクスカプセル）
- 幼児/女性用プロバイオティクスのタイプ別販売量
- 幼児/女性用プロバイオティクスのタイプ別売上
- 幼児/女性用プロバイオティクスのタイプ別価格
・アプリケーション別市場規模（幼児、女性）
- 幼児/女性用プロバイオティクスのアプリケーション別販売量
- 幼児/女性用プロバイオティクスのアプリケーション別売上
- 幼児/女性用プロバイオティクスのアプリケーション別価格
・北米市場
- 北米の幼児/女性用プロバイオティクス市場規模（タイプ別、アプリケーション別）
- 主要国別の幼児/女性用プロバイオティクス市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの幼児/女性用プロバイオティクス市場規模（タイプ別、アプリケーション別）
- 主要国別の幼児/女性用プロバイオティクス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の幼児/女性用プロバイオティクス市場規模（タイプ別、アプリケーション別）
- 主要国別の幼児/女性用プロバイオティクス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の幼児/女性用プロバイオティクス市場規模（タイプ別、アプリケーション別）
- 主要国別の幼児/女性用プロバイオティクス市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの幼児/女性用プロバイオティクス市場規模（タイプ別、アプリケーション別）
- 主要国別の幼児/女性用プロバイオティクス市場規模（トルコ、サウジアラビア）
・企業情報
DowDuPont、Koninklijke DSM、Pantheryx、Gerber Products、BioGaia、Metagenics、i-Health、LoveBug Nutrition、NOW Foods、By-Health、ChildLife、Nemans、CNFONO、Angel Yeast、Taiwan Xinyao livelihood、Weihai Baihe Biotechnology、Shanghai Yili Health、Beijing Hanmei Pharmaceutical
・産業チェーン及び販売チャネル分析
- 幼児/女性用プロバイオティクスの産業チェーン分析
- 幼児/女性用プロバイオティクスの原材料
- 幼児/女性用プロバイオティクスの生産プロセス
- 幼児/女性用プロバイオティクスの販売及びマーケティング
- 幼児/女性用プロバイオティクスの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 幼児/女性用プロバイオティクスの産業動向
- 幼児/女性用プロバイオティクスのマーケットドライバー
- 幼児/女性用プロバイオティクスの課題
- 幼児/女性用プロバイオティクスの阻害要因
・主な調査結果

Probiotics are live bacteria and yeasts promoted as having various health benefits. They’re usually added to yoghurts or taken as food supplements, and are often described as “good” or “friendly” bacteria.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Probiotics for Infants and Women is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Probiotics for Infants and Women is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Probiotics for Infants and Women is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Probiotics for Infants and Women include DowDuPont, Koninklijke DSM, Pantheryx, Gerber Products, BioGaia, Metagenics, i-Health, LoveBug Nutrition and NOW Foods, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Probiotics for Infants and Women manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Probiotics for Infants and Women market. Further, it explains the major drivers and regional dynamics of the global Probiotics for Infants and Women market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
DowDuPont
Koninklijke DSM
Pantheryx
Gerber Products
BioGaia
Metagenics
i-Health
LoveBug Nutrition
NOW Foods
By-Health
ChildLife
Nemans
CNFONO
Angel Yeast
Taiwan Xinyao livelihood
Weihai Baihe Biotechnology
Shanghai Yili Health
Beijing Hanmei Pharmaceutical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Probiotics for Infants and Women Segment by Type
Probiotic Powder
Probiotic Drops
Probiotic Capsules
Probiotics for Infants and Women Segment by Application
Infant
Women
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Probiotics for Infants and Women market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Probiotics for Infants and Women, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Probiotics for Infants and Women, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Probiotics for Infants and Women, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Probiotics for Infants and Women sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Probiotics for Infants and Women market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Probiotics for Infants and Women sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including DowDuPont, Koninklijke DSM, Pantheryx, Gerber Products, BioGaia, Metagenics, i-Health, LoveBug Nutrition and NOW Foods, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Probiotics for Infants and Women in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Probiotics for Infants and Women manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Probiotics for Infants and Women sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Probiotics for Infants and Women Product Introduction
1.2 Market by Type
1.2.1 Global Probiotics for Infants and Women Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Probiotic Powder
1.2.3 Probiotic Drops
1.2.4 Probiotic Capsules
1.3 Market by Application
1.3.1 Global Probiotics for Infants and Women Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infant
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Probiotics for Infants and Women Sales Estimates and Forecasts 2017-2028
2.2 Global Probiotics for Infants and Women Revenue Estimates and Forecasts 2017-2028
2.3 Global Probiotics for Infants and Women Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Probiotics for Infants and Women Sales by Region
2.4.1 Global Probiotics for Infants and Women Sales by Region (2017-2022)
2.4.2 Global Sales Probiotics for Infants and Women by Region (2023-2028)
2.5 Global Probiotics for Infants and Women Revenue by Region
2.5.1 Global Probiotics for Infants and Women Revenue by Region (2017-2022)
2.5.2 Global Probiotics for Infants and Women Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Probiotics for Infants and Women Sales by Manufacturers
3.1.1 Global Top Probiotics for Infants and Women Manufacturers by Sales (2017-2022)
3.1.2 Global Probiotics for Infants and Women Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Probiotics for Infants and Women in 2021
3.2 Global Probiotics for Infants and Women Revenue by Manufacturers
3.2.1 Global Probiotics for Infants and Women Revenue by Manufacturers (2017-2022)
3.2.2 Global Probiotics for Infants and Women Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Probiotics for Infants and Women Revenue in 2021
3.3 Global Probiotics for Infants and Women Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Probiotics for Infants and Women Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Probiotics for Infants and Women Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Probiotics for Infants and Women Sales by Type
4.1.1 Global Probiotics for Infants and Women Historical Sales by Type (2017-2022)
4.1.2 Global Probiotics for Infants and Women Forecasted Sales by Type (2023-2028)
4.1.3 Global Probiotics for Infants and Women Sales Market Share by Type (2017-2028)
4.2 Global Probiotics for Infants and Women Revenue by Type
4.2.1 Global Probiotics for Infants and Women Historical Revenue by Type (2017-2022)
4.2.2 Global Probiotics for Infants and Women Forecasted Revenue by Type (2023-2028)
4.2.3 Global Probiotics for Infants and Women Revenue Market Share by Type (2017-2028)
4.3 Global Probiotics for Infants and Women Price by Type
4.3.1 Global Probiotics for Infants and Women Price by Type (2017-2022)
4.3.2 Global Probiotics for Infants and Women Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Probiotics for Infants and Women Sales by Application
5.1.1 Global Probiotics for Infants and Women Historical Sales by Application (2017-2022)
5.1.2 Global Probiotics for Infants and Women Forecasted Sales by Application (2023-2028)
5.1.3 Global Probiotics for Infants and Women Sales Market Share by Application (2017-2028)
5.2 Global Probiotics for Infants and Women Revenue by Application
5.2.1 Global Probiotics for Infants and Women Historical Revenue by Application (2017-2022)
5.2.2 Global Probiotics for Infants and Women Forecasted Revenue by Application (2023-2028)
5.2.3 Global Probiotics for Infants and Women Revenue Market Share by Application (2017-2028)
5.3 Global Probiotics for Infants and Women Price by Application
5.3.1 Global Probiotics for Infants and Women Price by Application (2017-2022)
5.3.2 Global Probiotics for Infants and Women Price Forecast by Application (2023-2028)
6 North America
6.1 North America Probiotics for Infants and Women Market Size by Type
6.1.1 North America Probiotics for Infants and Women Sales by Type (2017-2028)
6.1.2 North America Probiotics for Infants and Women Revenue by Type (2017-2028)
6.2 North America Probiotics for Infants and Women Market Size by Application
6.2.1 North America Probiotics for Infants and Women Sales by Application (2017-2028)
6.2.2 North America Probiotics for Infants and Women Revenue by Application (2017-2028)
6.3 North America Probiotics for Infants and Women Market Size by Country
6.3.1 North America Probiotics for Infants and Women Sales by Country (2017-2028)
6.3.2 North America Probiotics for Infants and Women Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Probiotics for Infants and Women Market Size by Type
7.1.1 Europe Probiotics for Infants and Women Sales by Type (2017-2028)
7.1.2 Europe Probiotics for Infants and Women Revenue by Type (2017-2028)
7.2 Europe Probiotics for Infants and Women Market Size by Application
7.2.1 Europe Probiotics for Infants and Women Sales by Application (2017-2028)
7.2.2 Europe Probiotics for Infants and Women Revenue by Application (2017-2028)
7.3 Europe Probiotics for Infants and Women Market Size by Country
7.3.1 Europe Probiotics for Infants and Women Sales by Country (2017-2028)
7.3.2 Europe Probiotics for Infants and Women Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Probiotics for Infants and Women Market Size by Type
8.1.1 Asia Pacific Probiotics for Infants and Women Sales by Type (2017-2028)
8.1.2 Asia Pacific Probiotics for Infants and Women Revenue by Type (2017-2028)
8.2 Asia Pacific Probiotics for Infants and Women Market Size by Application
8.2.1 Asia Pacific Probiotics for Infants and Women Sales by Application (2017-2028)
8.2.2 Asia Pacific Probiotics for Infants and Women Revenue by Application (2017-2028)
8.3 Asia Pacific Probiotics for Infants and Women Market Size by Region
8.3.1 Asia Pacific Probiotics for Infants and Women Sales by Region (2017-2028)
8.3.2 Asia Pacific Probiotics for Infants and Women Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Probiotics for Infants and Women Market Size by Type
9.1.1 Latin America Probiotics for Infants and Women Sales by Type (2017-2028)
9.1.2 Latin America Probiotics for Infants and Women Revenue by Type (2017-2028)
9.2 Latin America Probiotics for Infants and Women Market Size by Application
9.2.1 Latin America Probiotics for Infants and Women Sales by Application (2017-2028)
9.2.2 Latin America Probiotics for Infants and Women Revenue by Application (2017-2028)
9.3 Latin America Probiotics for Infants and Women Market Size by Country
9.3.1 Latin America Probiotics for Infants and Women Sales by Country (2017-2028)
9.3.2 Latin America Probiotics for Infants and Women Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Probiotics for Infants and Women Market Size by Type
10.1.1 Middle East and Africa Probiotics for Infants and Women Sales by Type (2017-2028)
10.1.2 Middle East and Africa Probiotics for Infants and Women Revenue by Type (2017-2028)
10.2 Middle East and Africa Probiotics for Infants and Women Market Size by Application
10.2.1 Middle East and Africa Probiotics for Infants and Women Sales by Application (2017-2028)
10.2.2 Middle East and Africa Probiotics for Infants and Women Revenue by Application (2017-2028)
10.3 Middle East and Africa Probiotics for Infants and Women Market Size by Country
10.3.1 Middle East and Africa Probiotics for Infants and Women Sales by Country (2017-2028)
10.3.2 Middle East and Africa Probiotics for Infants and Women Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 DowDuPont
11.1.1 DowDuPont Corporation Information
11.1.2 DowDuPont Overview
11.1.3 DowDuPont Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 DowDuPont Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 DowDuPont Recent Developments
11.2 Koninklijke DSM
11.2.1 Koninklijke DSM Corporation Information
11.2.2 Koninklijke DSM Overview
11.2.3 Koninklijke DSM Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Koninklijke DSM Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Koninklijke DSM Recent Developments
11.3 Pantheryx
11.3.1 Pantheryx Corporation Information
11.3.2 Pantheryx Overview
11.3.3 Pantheryx Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pantheryx Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pantheryx Recent Developments
11.4 Gerber Products
11.4.1 Gerber Products Corporation Information
11.4.2 Gerber Products Overview
11.4.3 Gerber Products Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Gerber Products Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Gerber Products Recent Developments
11.5 BioGaia
11.5.1 BioGaia Corporation Information
11.5.2 BioGaia Overview
11.5.3 BioGaia Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BioGaia Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioGaia Recent Developments
11.6 Metagenics
11.6.1 Metagenics Corporation Information
11.6.2 Metagenics Overview
11.6.3 Metagenics Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Metagenics Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Metagenics Recent Developments
11.7 i-Health
11.7.1 i-Health Corporation Information
11.7.2 i-Health Overview
11.7.3 i-Health Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 i-Health Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 i-Health Recent Developments
11.8 LoveBug Nutrition
11.8.1 LoveBug Nutrition Corporation Information
11.8.2 LoveBug Nutrition Overview
11.8.3 LoveBug Nutrition Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 LoveBug Nutrition Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 LoveBug Nutrition Recent Developments
11.9 NOW Foods
11.9.1 NOW Foods Corporation Information
11.9.2 NOW Foods Overview
11.9.3 NOW Foods Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 NOW Foods Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NOW Foods Recent Developments
11.10 By-Health
11.10.1 By-Health Corporation Information
11.10.2 By-Health Overview
11.10.3 By-Health Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 By-Health Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 By-Health Recent Developments
11.11 ChildLife
11.11.1 ChildLife Corporation Information
11.11.2 ChildLife Overview
11.11.3 ChildLife Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 ChildLife Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ChildLife Recent Developments
11.12 Nemans
11.12.1 Nemans Corporation Information
11.12.2 Nemans Overview
11.12.3 Nemans Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Nemans Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Nemans Recent Developments
11.13 CNFONO
11.13.1 CNFONO Corporation Information
11.13.2 CNFONO Overview
11.13.3 CNFONO Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 CNFONO Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 CNFONO Recent Developments
11.14 Angel Yeast
11.14.1 Angel Yeast Corporation Information
11.14.2 Angel Yeast Overview
11.14.3 Angel Yeast Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Angel Yeast Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Angel Yeast Recent Developments
11.15 Taiwan Xinyao livelihood
11.15.1 Taiwan Xinyao livelihood Corporation Information
11.15.2 Taiwan Xinyao livelihood Overview
11.15.3 Taiwan Xinyao livelihood Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Taiwan Xinyao livelihood Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Taiwan Xinyao livelihood Recent Developments
11.16 Weihai Baihe Biotechnology
11.16.1 Weihai Baihe Biotechnology Corporation Information
11.16.2 Weihai Baihe Biotechnology Overview
11.16.3 Weihai Baihe Biotechnology Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Weihai Baihe Biotechnology Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Weihai Baihe Biotechnology Recent Developments
11.17 Shanghai Yili Health
11.17.1 Shanghai Yili Health Corporation Information
11.17.2 Shanghai Yili Health Overview
11.17.3 Shanghai Yili Health Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Shanghai Yili Health Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Shanghai Yili Health Recent Developments
11.18 Beijing Hanmei Pharmaceutical
11.18.1 Beijing Hanmei Pharmaceutical Corporation Information
11.18.2 Beijing Hanmei Pharmaceutical Overview
11.18.3 Beijing Hanmei Pharmaceutical Probiotics for Infants and Women Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Beijing Hanmei Pharmaceutical Probiotics for Infants and Women Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Beijing Hanmei Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Probiotics for Infants and Women Industry Chain Analysis
12.2 Probiotics for Infants and Women Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Probiotics for Infants and Women Production Mode & Process
12.4 Probiotics for Infants and Women Sales and Marketing
12.4.1 Probiotics for Infants and Women Sales Channels
12.4.2 Probiotics for Infants and Women Distributors
12.5 Probiotics for Infants and Women Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Probiotics for Infants and Women Industry Trends
13.2 Probiotics for Infants and Women Market Drivers
13.3 Probiotics for Infants and Women Market Challenges
13.4 Probiotics for Infants and Women Market Restraints
14 Key Findings in The Global Probiotics for Infants and Women Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

【幼児/女性用プロバイオティクスについて】

幼児および女性用プロバイオティクスについて、その概念や特徴、種類、用途、関連技術などについて詳しくお話しします。プロバイオティクスとは、腸内に良い影響を与える生きた微生物を指し、健康を促進するために用いられます。特に幼児や女性には特有のニーズや健康上の配慮が必要であり、それに応じたプロバイオティクス製品が開発されています。

まず、幼児用プロバイオティクスについて考えます。幼児の腸内フローラは出生時から成長過程で形成され、さまざまな要因によって影響を受けます。特に、母乳や離乳食、環境要因、抗生物質の使用などが腸内細菌に影響を与え、免疫系や消化機能に関連するため、幼児期における腸内環境の整備は非常に重要です。

幼児用プロバイオティクスの主な特徴は、成長をサポートするために特に選ばれた菌株を含んでいる点です。例えば、ビフィドバクテリウムや乳酸菌などは、幼児の腸内での定着性が高く、消化吸収を助け、免疫機能を強化する役割を果たします。これらの菌株は、腸内環境を整え、便通を改善するのに寄与します。

次に、女性用プロバイオティクスについて考えてみましょう。女性は生理周期、妊娠、出産、更年期など、さまざまなホルモンバランスの変化を経験します。これに伴い、腸内フローラや免疫機能、さらにはメンタルヘルスにも影響が出ることがあります。そのため、女性用プロバイオティクスは、これらのニーズに応じた菌株を含むことが一般的です。

女性用プロバイオティクスに含まれる代表的な菌株には、ラクトバチルスやビフィドバクテリウム、ストレップトコッカスなどがあります。これらの菌株は、腸内の健康を維持し、膀胱や膣の健康をサポートすることが知られています。また、ストレスやホルモンの変動に対する心理的な影響を軽減することにも寄与するとされています。

種類についてですが、プロバイオティクスは大きく分けて、食品由来とサプリメント由来のものがあります。食品由来のプロバイオティクスは、ヨーグルトや発酵食品、キムチなどに自然に含まれている生きた微生物です。一方、サプリメント由来のプロバイオティクスは、特定の菌株を高濃度で含むカプセルや粉末状の製品です。

幼児および女性用のプロバイオティクスサプリメントは、特に利用が増えてきています。これは、腸内環境の改善や免疫力の向上を目的としており、毎日の食事からでは摂取しきれない特定の菌株を補うことができる点が魅力です。そのため、特に便秘や下痢などの消化器系の問題、または抗生物質の使用後の腸内環境の回復を目的とした利用が進んでいます。

用途としては、幼児用プロバイオティクスは特に便秘や腸内フローラのバランスを整えることを目的とする場合が多いです。また、他の病気やアレルギーの予防にも効果があるとされており、一定の効果が報告されています。女性用プロバイオティクスに関しては、腸内環境の改善だけでなく、女性特有の悩みや症状、例えば生理前症候群（PMS）や妊娠中の不快感を軽減するために使用されることが多いです。

関連技術としては、プロバイオティクスの製造過程や保存技術が挙げられます。特に、菌株を生きた状態で腸まで届けるための技術開発が重要な課題となっています。これには、エンカプセル化技術や安定化技術が用いられ、製品の効果を持続させることが求められています。また、腸内フローラの多様性を評価するためのマイクロバイオーム解析技術も進化しており、より個別化されたプロバイオティクスの開発が期待されています。

最近の研究では、プロバイオティクスと腸内フローラの関連がますます明らかになってきています。腸内フローラは、免疫系、代謝、さらには心の健康にまで影響を与えることが報告されており、プロバイオティクスを通じた健康への貢献が注目されています。特に、幼児や女性は、健康問題に対する感受性が高く、それに合わせたプロバイオティクスの利用が求められています。

このように、幼児および女性用プロバイオティクスは、特有のニーズに応じた製品が多く開発されており、今後もさらなる研究と技術の進歩が期待されています。腸内環境の改善や免疫力の向上を通じて、健康をサポートする重要な役割を担っていると言えるでしょう。プロバイオティクスの利用を通じて、より良い健康状態を維持し、人生の質を向上させるための選択肢が広がっていくことを期待しています。